The effect of verapamil on plasma lipids and lipoproteins was studied in 64 patients taking part in a double blind controlled trial of verapamil versus placebo in post myocardial infarction. During a six month treatment period no significant difference was seen in plasma cholesterol, triglycerides, high density lipoproteins or low density lipoproteins.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.0954-6820.1984.tb08678.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!